Know Cancer

or
forgot password


N/A
18 Years
50 Years
Not Enrolling
Female
Polycystic Ovarian Syndrome,, Nonalcoholic Fatty Liver Disease

Thank you

Trial Information

Inclusion Criteria


Workup - history for menstrual pattern; Clinical evaluation for features of
hyperandrogenism; ultrasonographic documentation of ovarian morphology; follicular phase
hormonal profile for validation of the diagnosis and for ruling out other pathologies
which may cause anovulation.

Liver profiling - The following blood tests will be used for the biochemical profiling:
fasting glucose and insulin, CRP, HDL-cholesterol, triglycerides, AST, ALT, GGT, LDH,
alkaline phosphatase, total bilirubin, direct bilirubin, ferritin, HBA1C and micro albumin
ratio.

FibroScan® will be used to measure liver stiffness, as previously described

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Authority:

Israel: Ministry of Health

Study ID:

0068-12-ZIV

NCT ID:

NCT01735799

Start Date:

November 2012

Completion Date:

Related Keywords:

  • Polycystic Ovarian Syndrome,
  • Nonalcoholic Fatty Liver Disease
  • Fatty Liver
  • Liver Diseases
  • Polycystic Ovary Syndrome

Name

Location